๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The effect of peritoneovenous shunting on catecholamine metabolism in patients with hepatic ascites

โœ Scribed by Professor Laurence M. Blendis; Michael J. Sole; Peter Campbell; Alan G. Lossing; Paul D. Greig; Bryce R. Taylor; Bernard Langer


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
555 KB
Volume
7
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


The elevated catecholamine levels in cirrhotic patienta with ascites have been propaeed to be due to sympathetic overactivity secondary either to reduced intraveocular volume or to an underlying cardiovascular abnormality such as reduced pressor responsiveness. Furthermore, these elevated catecholamine levels have been proposed to be involved in the pathogenesis of salt and water retention. Therefore, the effect of peritoneo-~8801111 shunting on the circulating levels and renal excretion of catecholamiges were studied in six patients with lllllseive refractive ascites preoperative within the firtat 8 hr poetoperative and by 2 weeks postoperative under metabolic conditions. The recirculation of ascites into the intravascular compartment resulted perioperatively in significant rises in cardiac output (p = 0.001), para-amino-hippurate clearance (p = 0.08), creatinine clearancet, diuresis (p = 0.06) and natriuresis (p = 0.06).

SyetemiC blood pressure remained unchanged while systemic vnscular resistance decreased (p < 0.05).

Preoperative circulating levels of free catecholamine were highly elevated, and renal vein concentrations were about 25% higher than renal arterial levels. Perioperatively, there was little change in circulating catecholamine levels or distribution of renal blood flow al- tho-renal artery and vein concentrations tended to equalize.

In contrast by 2 weeke postoperatively, free catecholamine levels had fallen to within the normal ranges: mean norepinephrine from 1,477.6 f 194.6 to 395 f 62.9 pg per ml (p < 0.06); epinephrine from 276 f 74.2 to 65.7 f 16.0 pg per ml (p < 0.02), and dopamine from 325.6 f 175.2 to 47.9 f 6.3 pg per ml. There was little change in circulating conjugated catecholamine levels, either urinary excretion or clearance of cateeholamines, except epineplwhe clearance which rose significantly (p < 0.05). Despite the normalization of circulating free catechdamine levels, the patients tended to remain hypotemdve with a low peripheral vascular resistance. The retarn of circulating free catecholamine levels to normal following reexpansion of the intravascular volume by peritoneovenous shunting are in favor of their being elevated in reeponse to vascular underfilling.


๐Ÿ“œ SIMILAR VOLUMES


Renal effects of transjugular intrahepat
โœ Alexander L. Gerbes; Veit Gรผlberg; Tobias Waggershauser; Josef Holl; Maximilian ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 119 KB ๐Ÿ‘ 2 views

Renal effects of the transjugular intrahepatic portosystemic shunt (TIPS) were compared in 6 patients without ascites (group 1), 11 patients with ascites responding to diuretic treatment (group 2), and 6 patients with refractory ascites (group 3). Seven days after insertion of TIPS, 24-hour urinary

Splanchnic and Hepatic Metabolism of Som
โœ Susan Webb; David Kravetz; Jaume Bosch; John A. H. Wass; Joan Evans; Ramon Gomis ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 559 KB

Experimental data suggest that somatostatin is metabolized by both liver and kidneys. Results in humans are conflicting. By studying a group of cirrhotic patients with surgically induced end-to-side portacaval shunts, basally and during a somatostatin infusion, we have been able to analyze separatel

Effects of systemic prostaglandin e on h
โœ Andrea Fabbri; Giampaolo Bianchi; Mara Brizi; Elisabetta Bugianesi; Donatella Ma ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 115 KB ๐Ÿ‘ 2 views

Prostaglandins of the E (PGE) series have long been considered ''catabolic'' hormones, but recent data suggest that they may be secreted in critically ill patients to counteract stress hormones, stimulating protein synthesis. Their use is under scrutiny to improve hepatic microcirculation and as cyt